Myomo Q2 Earnings Call Highlights

1 hour ago 1

MarketBeat

Sun, August 9, 2026 astatine 2:04 PM CDT 6 min read

Key Points

  • 3 Underrated Robotics Stocks Poised for Major Growth

Myomo (NYSEAMERICAN:MYO) reported second-quarter 2026 gross maturation of 21% arsenic the wearable robotics institution continued shifting its diligent acquisition strategy toward recurring referral sources and expanded reimbursement relationships.

Revenue for the 4th totaled $11.7 million, compared with the prior-year period, driven by a 2% summation successful mean selling terms to astir $55,500 and a 19% emergence successful recognized gross units to 211 MyoPro devices. The institution recorded a quarterly grounds of 255 MyoPro orders, up 23% twelvemonth implicit year.

→ No Hangover: Revisiting Microsoft One Week After Earnings

  • Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth

Chief Executive Officer Paul Gudonis said the institution is emphasizing recurring referrals, reimbursement access, operating subject and merchandise improvement alternatively than relying chiefly connected direct-to-consumer marketing.

Referral Strategy Gains Momentum

Recurring diligent sources represented 53% of second-quarter revenue, doubling from 26% a twelvemonth earlier and reaching Myomo's 50% nonsubjective six months up of schedule. The institution said it added much than 150 referral sites during the quarter, bringing its progressive web to much than 300 locations.

→ MarketBeat Week successful Review – 08/03 - 08/07

Within recurring channels, direct-billing referrals done the MyoConnect programme accounted for 23% of full revenue, up from 20% successful the archetypal quarter. International gross represented 17% of gross and grew 32% twelvemonth implicit year, portion the U.S. orthotics and prosthetics, oregon O&P, transmission represented 10% of gross and grew 130%. Veterans Affairs patients accounted for 3% of quarterly revenue.

Read Entire Article